Clinical trialsRegistry-verifiedPrivate-market model

Zentralinstitut für Seelische Gesundheit (ZI) Mannheim — Studienzentrum

Mannheim, Germany

Treatment & access

Treatments offeredLSD (MM120: clinical trial)
Access routeTrial
Cost & coverage (registry status)Free within clinical trial
Websitehttps://www.zi-mannheim.de

Related listings

These records belong to the same organisation. They are listed separately because each is a distinct programme or location.

Another programme at this clinicCentral Institute of Mental Health : Clinical trials
Another programme at this clinicZentralinstitut für Seelische Gesundheit (ZI) Mannheim : PAT

About this provider

Compiled from the registry data on this page.

The Panorama study, a Phase 3 clinical trial of MM120 (lysergide, a pharmaceutical form of LSD) in generalized anxiety disorder, lists Zentralinstitut für Seelische Gesundheit (ZI) Mannheim: Studienzentrum in Mannheim, Germany, among its sites. The trial is registered on ClinicalTrials.gov under NCT06809595, the registry source cited by this record. As of 2026-08-07 the registry status is ACTIVE_NOT_RECRUITING: recruitment has closed, so this site is not accepting new participants. For enrolled participants, treatment within the trial is free of charge. The record was last verified on 2026-08-07.

Services & programs

Programs & studies

Program	Kind	Status
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (NCT06809595) Auto-linked from the record’s registry sources; status refreshed from ClinicalTrials.gov. Key entry criteria by protocol: age 18–74 · patients only (no healthy volunteers). Full inclusion and exclusion criteria on the registry. The research team makes the final eligibility decision.	clinical trial	Active Not Recruiting

1 more verified providers within 50 km

Alzey · 38 kmFacharztpraxis Dr. med. Jochen Klinga — Esketamin-Ambulanz : Spravato®

See them on the provider map →

Common questions

What does treatment cost at Zentralinstitut für Seelische Gesundheit (ZI) Mannheim — Studienzentrum?

Free within clinical trial As published by the provider (verified 2026-08-07).

Is treatment at Zentralinstitut für Seelische Gesundheit (ZI) Mannheim — Studienzentrum covered by insurance?

MM120 (lysergide) Phase 3 Panorama study in generalized anxiety disorder. Registry status 2026-08-07: ACTIVE_NOT_RECRUITING - recruitment closed (EU recruitment ended 2026-05-15); do not route patients. (Verified 2026-08-07.)

Verification

License / registryCTIS (EU Clinical Trials Information System)
Official registryhttps://euclinicaltrials.eu/ctis-public/view/2024-513572-17-00
Official registryhttps://clinicaltrials.gov/study/NCT06809595
Provider websitehttps://www.zi-mannheim.de
Last verified2026-08-07

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to Zentralinstitut für Seelische Gesundheit (ZI) Mannheim — Studienzentrum, with your consent.

What to prepare before you enquire

A referral or the contact details of your treating clinician
A list of medications you have tried (names, doses, duration)
A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.

Check my fit & enquire